Low Doses of Bevacizumab Tested for Retinopathy of Prematurity
Phase 1 study suggests that intravitreous injection of 0.004 mg may be lowest effective dose
COVID-19-Linked Changes Reported in Rheumatic Disease Patient Care
Forty-two percent of patients report change in care in previous two weeks
Premature Posting of Remdesivir Findings Were ‘Inconclusive’
Due to low enrollment, study was 'underpowered to enable statistically meaningful conclusions'
FDA Warns About Treating COVID-19 With Unproven Drugs
Chloroquine, hydroxychloroquine may trigger potentially fatal heart rhythm problems in COVID-19 patients
Higher Manganese Intake May Be Tied to Lower Type 2 Diabetes Risk
Association may be partially mediated by inflammatory biomarkers
Clascoterone Cream Safe, Effective for Acne Treatment
Clascoterone cream, 1 percent, is a novel topical androgen receptor inhibitor
Lopinavir/Ritonavir, Umifenovir Ineffective for Mild COVID-19
Rate of positive-to-negative conversion of SARS-CoV-2 did not differ for drug therapy versus standard care
ACEIs/ARBs Not Linked to Severity or Mortality of COVID-19
Percentage of patients with hypertension taking ACEIs/ARBs similar for survivors, nonsurvivors
White House Announces Payment Plan for Uninsured COVID-19 Patients
Doctors can submit bills for these patients directly to the government and be paid at Medicare rates
IBD Symptoms in Pregnancy Tied to Higher C-Section Rate, IUGR
Pregnancy less common among women with inflammatory bowel disease
